Candelanza, Jessa Mae G.
HRN: 21-72-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
CEFTRIAXONE 1G (VIAL)
06/28/2023
07/04/2023
IVT
365mg
Q12
Pneumonia, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes